Latest news
Invetech, Haemonetics, and Coramed Technologies Receive 2016 Good Design Award® for Development of the TEG® 6s
Jul 16, 2023Her Symptoms Suggested Long Covid. But Was That Too Obvious?
May 03, 2023Lysosomal
Apr 13, 2023Biochemical Reagents Market 2023 Unveiling Future Growth, Explores New Trends and Forecasts
Mar 16, 2023US FDA approves Cue Health’s at
Apr 27, 2023Aurinia Files Form S
Apr 01, 2023
$34.4 million in net revenue for the first quarter of 2023; an increase of 59% over the first quarter of the prior year
Increases 2023 revenue guidance range to $135 - $155 million from net product sales of LUPKYNIS
News Provided by Business Wire via QuoteMedia